Vivani Medical Inc VANI Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Sep 21, 2023 (filed on Sep 22, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

398

Price:

$0.93
Sep 20, 2023 (filed on Sep 22, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

21,028

Price:

$0.92
Sep 18, 2023 (filed on Sep 18, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

66,743

Price:

$0.96
Sep 14, 2023 (filed on Sep 18, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

35,036

Price:

$0.95
Sep 12, 2023 (filed on Sep 12, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

5,145

Price:

$0.96
Sep 11, 2023 (filed on Sep 12, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,854

Price:

$0.95
Sep 08, 2023 (filed on Sep 12, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

6,998

Price:

$0.94
Sep 07, 2023 (filed on Sep 07, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

33,700

Price:

$0.94
Sep 06, 2023 (filed on Sep 07, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

14,570

Price:

$0.94
Sep 05, 2023 (filed on Sep 07, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

4,997

Price:

$0.93

Filings by filing date

Sep 21, 2023 (filed on Sep 22, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

398

Price:

$0.93
Sep 20, 2023 (filed on Sep 22, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

21,028

Price:

$0.92
Sep 18, 2023 (filed on Sep 18, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

66,743

Price:

$0.96
Sep 14, 2023 (filed on Sep 18, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

35,036

Price:

$0.95
Sep 12, 2023 (filed on Sep 12, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

5,145

Price:

$0.96
Sep 11, 2023 (filed on Sep 12, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,854

Price:

$0.95
Sep 08, 2023 (filed on Sep 12, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

6,998

Price:

$0.94
Sep 07, 2023 (filed on Sep 07, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

33,700

Price:

$0.94
Sep 06, 2023 (filed on Sep 07, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

14,570

Price:

$0.94
Sep 05, 2023 (filed on Sep 07, 2023)

Insider Name:

Williams Gregg

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

4,997

Price:

$0.93

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	5858 Horton Street, Suite 280 EMERYVILLE CA 94608
Tel:	N/A
Website:	www.secondsight.com
IR:	See website

Key People

Adam Mendelsohn Chief Executive Officer, Director	Brigid A. Makes Chief Financial Officer	Truc Le Chief Operating Officer
Donald Dwyer Chief Business Officer	Lisa Porter Chief Medical Officer

Business Overview

Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. NanoPortal implant technology's initial focus is on peptide therapeutics for the treatment of patients with metabolic diseases. It operates through two segments: Biopharm Division and Neuromodulation Division. Its pipeline product candidates include NPM-119, NPM-159, NPM-139 and OKV-119. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. NPM-159 is in feasibility testing for the treatment of non-alcoholic steatohepatitis (NASH). It is also in the development of neurostimulation systems to help patients recover critical body functions.

Financial Overview

For the six months ended 30 June 2023, Vivani Medical Inc revenues was not reported. Net loss increased 60% to $12.8M. Higher net loss reflects General and administrative increase from $1.9M to $5.4M (expense), Research and Development, net increase of 36% to $7.3M (expense), Stock-based Compensation in SGA.. increase of 64% to $361K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.22 to -$0.25.

Employees:	50 as of Dec 31, 2022

Reporting Currency:	U.S. Dollars
Enterprise value:	$15.28M as of Jun 30, 2023
Annual revenue (TTM):	$0.00M as of Jun 30, 2023
EBITDA (TTM):	-$26.30M as of Jun 30, 2023
Net annual income (TTM):	-$18.71M as of Jun 30, 2023
Free cash flow (TTM):	-$24.98M as of Jun 30, 2023
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	50,818,799 as of Aug 10, 2023
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization